In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice

BR Blazar, PA Taylor, PS Linsley, +1

Blood

In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice

BR Blazar, PA Taylor, PS Linsley, +1

Blood

Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts

BR Blazar, PA Taylor, Sidney R. Smith, +1

Blood

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts

BR Blazar, PA Taylor, Angela Panoskaltsis‐Mortari, +2

Blood

In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities

BR Blazar, PA Taylor, DA Vallera

Blood

Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients

BR Blazar, PA Taylor, DA Vallera

Blood

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens

BR Blazar, PA Taylor, Angela Panoskaltsis‐Mortari, +2

Blood

Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens

BR Blazar, PA Taylor, JA Bluestone, +1

Blood

Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow [published erratum appears in Blood 1994 Jun 1;83(11):3424-5]

BR Blazar, PA Taylor, SN Sehgal, +1

Blood

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A

BR Blazar, PA Taylor, Angela Panoskaltsis‐Mortari, +2

Blood